. Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study. Curr Alzheimer Res. 2010 Jun;7(4):348-57. PubMed.


Please login to recommend the paper.


  1. Timely paper which uses data from the CATIE-AD trial to illustrate how cost-effectiveness analyses can be done to explore the relationship of clinical benefit to cost. Similar analyses are likely to be applied to drugs introduced for AD and other neurodegenerative diseases in the future.

Make a Comment

To make a comment you must login or register.